Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients

AIMS: Immunocompromised patients have been excluded from studies of SARS-CoV-2 messenger RNA vaccines. The immune response to vaccines against other infectious agents has been shown to be blunted in such patients. We aimed to analyse the humoral and cellular response to prime-boost vaccination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Schramm, René, Costard-Jäckle, Angelika, Rivinius, Rasmus, Fischer, Bastian, Müller, Benjamin, Boeken, Udo, Haneya, Assad, Provaznik, Zdenek, Knabbe, Cornelius, Gummert, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267767/
https://www.ncbi.nlm.nih.gov/pubmed/34241676
http://dx.doi.org/10.1007/s00392-021-01880-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267767/
https://www.ncbi.nlm.nih.gov/pubmed/34241676
http://dx.doi.org/10.1007/s00392-021-01880-5

Ejemplares similares